Combination Study of SV-BR-1-GM With Retifanlimab
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- George E Peoples, MD, FACS
LumaBridge LLC
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
- St. Joseph Heritage Healthcare
Santa Rosa, California, United States
- Mayo Clinic Florida
Jacksonville, Florida, United States
- University of Miami/sylvester at Plantation
Plantation, Florida, United States
- Carle Cancer Institute
Urbana, Illinois, United States
- Cancer Center of Kansas (cck)
Wichita, Kansas, United States
- the Center for Cancer and Blood Disorders A Division of American Oncology Partners Md
Bethesda, Maryland, United States
- St Vincent-Frontier Cancer Center
Billings, Montana, United States
- Nebraska Cancer Specialists
Omaha, Nebraska, United States
- Overlook Medical Center Oncology Research, Atlantic Health System
Summit, New Jersey, United States
- Manhattan Hematology Oncology Associates (mhoa)
Manhattan, New York, United States
- Mary Crowley Cancer Research
Dallas, Texas, United States
- Tranquil Clinical Research
Webster, Texas, United States
- Hematology-Oncology Associates of Fredericksburg, Inc
Fredericksburg, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Mar 2018
- Primary completion
- 24 Mar 2026
- Completion
- 24 Mar 2026
- Last update posted
- 27 Mar 2026
- Registered enrollment
- 36
- Registry id
- NCT03328026
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.